Literature DB >> 15955487

Gray matter volume reduction in the chronic fatigue syndrome.

Floris P de Lange1, Joke S Kalkman, Gijs Bleijenberg, Peter Hagoort, Jos W M van der Meer, Ivan Toni.   

Abstract

The chronic fatigue syndrome (CFS) is a disabling disorder of unknown etiology. The symptomatology of CFS (central fatigue, impaired concentration, attention and memory) suggests that this disorder could be related to alterations at the level of the central nervous system. In this study, we have used an automated and unbiased morphometric technique to test whether CFS patients display structural cerebral abnormalities. We mapped structural cerebral morphology and volume in two cohorts of CFS patients (in total 28 patients) and healthy controls (in total 28 controls) from high-resolution structural magnetic resonance images, using voxel-based morphometry. Additionally, we recorded physical activity levels to explore the relation between severity of CFS symptoms and cerebral abnormalities. We observed significant reductions in global gray matter volume in both cohorts of CFS patients, as compared to matched control participants. Moreover, the decline in gray matter volume was linked to the reduction in physical activity, a core aspect of CFS. These findings suggest that the central nervous system plays a key role in the pathophysiology of CFS and point to a new objective and quantitative tool for clinical diagnosis of this disabling disorder.

Entities:  

Mesh:

Year:  2005        PMID: 15955487     DOI: 10.1016/j.neuroimage.2005.02.037

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  56 in total

1.  Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome.

Authors:  M A Zinn; M L Zinn; I Valencia; L A Jason; J G Montoya
Journal:  Biol Psychol       Date:  2018-05-23       Impact factor: 3.251

2.  Structural brain changes versus self-report: machine-learning classification of chronic fatigue syndrome patients.

Authors:  Landrew S Sevel; Jeff Boissoneault; Janelle E Letzen; Michael E Robinson; Roland Staud
Journal:  Exp Brain Res       Date:  2018-05-30       Impact factor: 1.972

Review 3.  Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms.

Authors:  Frank Nm Twisk
Journal:  World J Methodol       Date:  2015-06-26

4.  Altered control of postural sway following cerebral infarction: a cross-sectional analysis.

Authors:  B Manor; K Hu; P Zhao; M Selim; D Alsop; P Novak; L Lipsitz; V Novak
Journal:  Neurology       Date:  2010-02-09       Impact factor: 9.910

5.  Investigating neural mechanisms of change of cognitive behavioural therapy for chronic fatigue syndrome: a randomized controlled trial.

Authors:  Marieke E van Der Schaaf; Iris C Schmits; Megan Roerink; Dirk E M Geurts; Ivan Toni; Karin Roelofs; Floris P De Lange; Urs M Nater; Jos W M van der Meer; Hans Knoop
Journal:  BMC Psychiatry       Date:  2015-07-03       Impact factor: 3.630

6.  A systematic review of chronic fatigue syndrome: don't assume it's depression.

Authors:  James P Griffith; Fahd A Zarrouf
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 7.  Targeting voltage-gated calcium channels for neuropathic pain management.

Authors:  Danielle Perret; Z David Luo
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 8.  Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesis.

Authors:  Stefania Fulle; Tiziana Pietrangelo; Rosa Mancinelli; Raoul Saggini; Giorgio Fanò
Journal:  J Muscle Res Cell Motil       Date:  2008-02-15       Impact factor: 2.698

Review 9.  Exercise and fatigue.

Authors:  Wim Ament; Gijsbertus J Verkerke
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

10.  Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures.

Authors:  E M Mowry; A Beheshtian; E Waubant; D S Goodin; B A Cree; P Qualley; R Lincoln; M F George; R Gomez; S L Hauser; D T Okuda; D Pelletier
Journal:  Neurology       Date:  2009-05-19       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.